Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

被引:149
作者
Heideman, D. A. M. [1 ]
Hesselink, A. T. [1 ]
Berkhof, J. [2 ]
van Kemenade, F. [1 ]
Melchers, W. J. G. [3 ]
Daalmeijer, N. Fransen [1 ]
Verkuijten, M. [1 ]
Meijer, C. J. L. M. [1 ]
Snijders, P. J. F. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands
关键词
RISK HUMAN-PAPILLOMAVIRUS; WOMEN;
D O I
10.1128/JCM.05552-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.
引用
收藏
页码:3983 / 3985
页数:3
相关论文
共 8 条
[1]   Evaluation of a Prototype Real-Time PCR Assay for Carcinogenic Human Papillomavirus (HPV) Detection and Simultaneous HPV Genotype 16 (HPV16) and HPV18 Genotyping [J].
Castle, Philip E. ;
Sadorra, Mark ;
Lau, Tiffany ;
Aldrich, Carrie ;
Garcia, Francisco A. R. ;
Kornegay, Janet .
JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (10) :3344-3347
[2]   Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening [J].
Luisa Mateos, Maria ;
Chacon de Antonio, Jesus ;
Rodriguez-Dominguez, Mario ;
Sanz, Itziar ;
Dolores Rubio, Maria .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (06) :411-414
[3]   Validation of high-risk HPV tests for primary cervical screening [J].
Meijer, C. J. L. M. ;
Berkhof, H. ;
Heideman, D. A. M. ;
Hesselink, A. T. ;
Snijders, P. J. F. .
JOURNAL OF CLINICAL VIROLOGY, 2009, 46 :S1-S4
[4]   Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older [J].
Meijer, Chris J. L. M. ;
Berkhof, Johannes ;
Castle, Philip E. ;
Hesselink, Albertus T. ;
Franco, Eduardo L. ;
Ronco, Guglielmo ;
Arbyn, Marc ;
Bosch, F. Xavier ;
Cuzick, Jack ;
Dillner, Joakim ;
Heideman, Danielle A. M. ;
Snijders, Peter J. F. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) :516-520
[5]   Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening [J].
Rijkaart, Dorien C. ;
Berkhof, Johannes ;
van Kemenade, Folkert J. ;
Coupe, Veerle M. H. ;
Hesselink, Albertus T. ;
Rozendaal, Lawrence ;
Heideman, Danielle A. M. ;
Verheijen, Ren H. ;
Bulk, Saskia ;
Verweij, Wim M. ;
Snijders, Peter J. F. ;
Meijer, Chris J. L. M. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (03) :602-610
[6]   Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study) [J].
Rijkaart, Dorien C. ;
Berkhof, Johannes ;
van Kemenade, Folkert J. ;
Rozendaal, Lawrence ;
Verheijen, Rene H. M. ;
Bulk, Saskia ;
Herreilers, Miriam E. ;
Verweij, Wim M. ;
Snijders, Peter J. F. ;
Meijer, Chris J. L. M. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (09) :2175-2181
[7]   High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology [J].
Stoler, Mark H. ;
Wright, Thomas C., Jr. ;
Sharma, Abha ;
Apple, Raymond ;
Gutekunst, Karen ;
Wright, Teresa L. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (03) :468-475
[8]   GP5+/6+PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes [J].
van den Brule, AJC ;
Pol, R ;
Fransen-Daalmeijer, N ;
Schouls, LM ;
Meijer, CJLM ;
Snijders, PJF .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :779-787